Skip to main content

Medicare Fee-For-Service Estimated Improper Payments Decline by $15 Billion Since 2016

 


CMS NEWS: Trump Administration Announces Medicare Fee-For-Service Estimated Improper Payments Decline by $15 Billion Since 2016

11/16/2020

Centers for Medicare & Medicaid ServicesCMS.gov News Room

CMS NEWS

FOR IMMEDIATE RELEASE
November 16, 2020

Contact: CMS Media Relations
(202) 690-6145 | CMS Media Inquiries

 

Trump Administration Announces Medicare Fee-For-Service Estimated Improper Payments Decline by $15 Billion Since 2016
Continued reduction marks fourth year Medicare FFS improper payment rate has been below 10% 

The Centers for Medicare & Medicaid Services (CMS) announced today that the Medicare Fee- For-Service (FFS) improper payment rate has continued to decline, reinforcing the Trump Administration and CMS’ commitment to strengthening Medicare and protecting taxpayer dollars. This translates to less fraud, waste and abuse that can increase the fiscal burden on the nation’s healthcare system.

Over the past four years, CMS’ aggressive corrective actions have led to an estimated $15 billion reduction of Medicare FFS improper payments. This reduction is a result of CMS’s steadfast efforts to identify the root causes of improper payments, implement action plans to reduce and prevent improper payments, and extend the Agency’s capacity to address emerging areas of risk through work groups and interagency collaborations.

 

“President Trump made a clear commitment to protect Medicare for our seniors, and to do that we must ensure that fraud and abuse doesn’t rob the program of precious resources,” said Administrator Seema Verma. “From the beginning this administration has doubled down on our commitment to protect taxpayer dollars and this year’s continued reduction in Medicare improper payments is a direct result of those actions.”

 

Taxpayer Savings

The reduction in improper payments represents considerable progress and savings for American taxpayers and resulted from concerted CMS efforts to address improper payments at the source. The Medicare FFS estimated improper payment rate decreased to 6.27% in FY 2020, from 7.25% in FY 2019, the fourth consecutive year the Medicare FFS improper payment rate has been below the 10% threshold for compliance established in the Payment Integrity Information Act of 2019. This year’s decrease was driven largely by progress in the following important areas:

  • Home health improvements, including clarifying documentation requirements and educating providers through the Targeted Probe and Educate program, resulted in a $5.9 billion decrease in estimated improper payments from FY 2016 to FY 2020.
  • Skilled nursing facility claims saw a $1 billion reduction in estimated improper payments in the last year due to a policy change related to the supporting information for physician certification and recertification for skilled nursing facility services, as well as CMS’ Targeted Probe and Educate efforts.

Healthcare costs are skyrocketing; by 2026, one out of every five tax dollars will be spent on healthcare. To constrain unsustainable cost growth, CMS must continue to ensure payments are made according to the rules. Improper payments represent payments that don’t meet program requirements – intentional or otherwise – and contribute to inaccurate spending of Americans’ tax dollars, but are not all representative of fraud. Rather, improper payments might be overpayments or underpayments, or payments where sufficient information was not provided to determine whether a payment is proper or not.

CMS has developed a five-pillar program integrity strategy to modernize the Agency’s approach to reducing the improper payment rate while protecting its programs for future generations:

  • Stop Bad CMS works with law enforcement agencies to crack down on “bad actors” who have defrauded federal health programs.
  • Prevent Fraud. Rather than the expensive and inefficient “pay & chase” model, CMS prevents and eliminates fraud, waste and abuse on the front end by proactively strengthening vulnerabilities before they are
  • Mitigate Emerging Programmatic Risks. CMS is exploring ways to identify and reduce program integrity risks related to value-based payment programs by looking to experts in the healthcare community for lessons learned and best
  • Reduce Provider To assist rather than punish providers who make good faith claim errors, CMS is reducing burden on providers by making coverage and payment rules more easily accessible to them, educating them on CMS programs, and reducing documentation requirements that are duplicative or unnecessary.
  • Leverage New Technology. CMS is working to modernize its program integrity efforts by exploring innovative technologies like artificial intelligence and machine learning, which could allow the Medicare program to review compliance on more claims with less burden on providers and less cost to taxpayers.
###
Monday, November 16, 2020 11:19 PM
Centers for Medicare & Medicaid Services (CMS) Daily Digest Bulletin

Disclaimer: This guidance is to be used for an easy reference; the ICD-9-CM and ICD-10-CM code books and the Official Guidelines for Coding and Reporting are the authoritative references for accurate and complete coding. This blog may contain references or links to statutes, regulations, or other policy materials. It is not intended to take the place of either the written law or regulations.  The information presented herein is for general informational purposes only and is accurate as of the date of publication.

Popular posts from this blog

Guidelines for HIV coding

Chapter 1: Certain Infectious and Parasitic diseases (A00-B99) Human Immunodeficiency virus (HIV) Infections B20 Human immunodeficiency virus (HIV) disease (symptomatic) R75 Inconclusive laboratory evidence of human immunodeficiency virus (HIV) Z20.6 Contact with and exposure to human immunodeficiency virus (HIV) Z11.4 Encounter for screening for human immunodeficiency virus (HIV) Z71.7 human immunodeficiency virus [HIV] counseling Z21 Asymptomatic human immunodeficiency virus (HIV) infection status “Confirmation” does NOT require documentation for positive serology or culture for HIV; the provider’s diagnostic statement that the patient is HIV positive, or has an HIV-related illness is sufficient.   Once a patient is diagnosed with B20, they should never be assigned R75 or Z21. Sequencing of HIV Codes B20 should be sequenced as the first-listed diagnosis when patient is treated for an HIV related condition. Any non-related conditions get sequenced following t

Preliminary ICD-10-CM CMS HCC Mappings

The link below take you to the Preliminary ICD-10-CM Codes, CMS-HCC and RxHCC Models, Includes FY2014 preliminary list of  ICD-10 codes HCC Mappings from CMS. Last modified 9/30/2014.   Preliminary ICD-10-CM Mappings Diagnosis Code Description CMS-HCC PACE/ESRD Model Category V21 CMS-HCC Model Category V22 (clinically revised model implemented in 2014) RxHCC Model Category V04 CMS-HCC PACE/ESRD Model for 2015 Payment Year CMS-HCC Model for 2015 Payment Year RxHCC Model for 2015 Payment Year   #HCC  #ICD10  #CMS  #ICD9  #RiskAdjustment  #MedicalCoding #Mappings     Disclaimer : This guidance is to be used for an easy reference; the ICD-9-CM and ICD-10-CM code books and the Official Guidelines for Coding and Reporting are the authoritative references for accurate and complete coding. This blog may contain references or links to statutes, regulations, or other policy materials.

Major Depressive Disorder

Major depressive disorder According to the American Psychiatric Association, major depressive disorder can be seen in patients who have suffered a depressive episode lasting at least two weeks, as manifested by at least five of the following symptoms: depressed mood, loss of interest or pleasure in most or all activities, insomnia or hypersomnia, change in appetite or weight, psychomotor retardation or agitation, low energy, poor concentration, thoughts of worthlessness or guilt, and recurrent thoughts about death or suicidal ideation. Major depression is highly recurrent, with recurrent episodes occurring in 50% or more of patients. Remission and recovery from major depression Whether or not a patient is being treated for depression (e.g., counseling and/or medication), remission can be defined as a level of depressive symptoms basically indistinguishable from that in someone who has never been depressed. When reporting history of major depressive disorder, instead of coding V1